MannKind Corporation Total Non Current Liabilities 2011-2026 | MNKD

Annual Total Non Current Liabilities MannKind Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992
-	-	-	-	-	-	219 M	208 M	212 M	199 M	208 M	64.9 M	162 M	217 M	488 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
488 M	64.9 M	220 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	79.1 K	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	158 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	189 M	$ 1.61	2.55 %	$ 189 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
BioNTech SE BNTX	622 M	$ 92.14	1.33 %	$ 22.3 B	Germany
AstraZeneca PLC AZN	34.7 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	7.32 M	-	0.74 %	$ 768 M	Israel
Compugen Ltd. CGEN	31.3 M	$ 2.8	7.28 %	$ 262 M	Israel
Abcam plc ABCM	128 M	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	64 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	645 K	-	-18.52 %	$ 27.3 M	Britain
Enlivex Therapeutics Ltd. ENLV	383 M	$ 0.72	-0.37 %	$ 32.9 M	Israel
Affimed N.V. AFMD	13.4 M	-	-34.95 %	$ 21.5 M	Germany
Esperion Therapeutics ESPR	355 M	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	4.56 M	$ 32.59	-6.89 %	$ 877 M	USA
Forte Biosciences FBRX	10.5 M	$ 21.59	-1.86 %	$ 280 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Celyad Oncology SA CYAD	4.97 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	132 M	-	-	$ 344 M	USA
IMV IMV	8.95 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	497 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	1.06 M	-	-4.36 %	$ 27 M	USA
Gracell Biotechnologies GRCL	51.9 M	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	26.1 M	$ 14.88	-0.93 %	$ 213 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
InflaRx N.V. IFRX	678 K	$ 2.61	5.67 %	$ 176 M	Germany
Aeterna Zentaris AEZS	14 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 3.4	-1.16 %	$ 5.6 M	Israel
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Immuron Limited IMRN	94.6 K	$ 1.0	2.04 %	$ 231 M	Australia